曹波名中医经验祛瘀解毒治疗大肠癌之浅见

中华养生保健 ›› 2025, Vol. 43 ›› Issue (12): 39-42.

曹波名中医经验祛瘀解毒治疗大肠癌之浅见

杨乐, 曹波^*

贵州中医药大学第一附属医院肛肠科, 贵州贵阳, 550001

发布日期:2025-10-14
通讯作者: ^*曹波,E-mail：Caobo39666@163.com。
作者简介:杨乐（1984—）,男,汉族,籍贯：山东省聊城市,硕士研究生,主治医师,研究方向：中医肛肠疾病诊治。

A Preliminary Exploration of Famous TCM Practitioner Cao Bo's Experience in Treating Colorectal Cancer by Removing Stasis and Detoxifying

YANG Le, CAO Bo^*

Department of Coloproctology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, GuiYang GuiZhou, 550001, China

Published:2025-10-14

摘要/Abstract

摘要： 大肠癌危害巨大,发病率高。本文旨在总结曹波教授在长期临床实践过程中形成的临床经验及用药规律,提出痰湿瘀毒是大肠癌的关键致病因素,治疗大肠癌应遵循“补气养血、化痰燥湿、祛瘀解毒”之法,注重灵活运用药物,兼顾兼症的处理,并附病案举例。

关键词: 大肠癌, 祛瘀解毒, 名家经验

Abstract: Colorectal cancer is very harmful and has a high incidence rate. This paper aims to summarize professor Cao Bo in long-term clinical practice of clinical experience and medication rule, put forward phlegm dampness stasis is the key factor of colorectal cancer, treatment of colorectal cancer should follow the "fill qi nourishing blood, change phlegm dry dampness, remove stasis and detoxification" method, pay attention to the flexible use of drugs, both disease treatment, and sickness case, for example.

Key words: Colorectal cancer, Traditional Chinese Medicine, Dispelling blood stasis and detoxifying, Expert Experience

中图分类号:

R249

杨乐, 曹波. 曹波名中医经验祛瘀解毒治疗大肠癌之浅见[J]. 中华养生保健, 2025, 43(12): 39-42.

YANG Le, CAO Bo. A Preliminary Exploration of Famous TCM Practitioner Cao Bo's Experience in Treating Colorectal Cancer by Removing Stasis and Detoxifying[J]. ZHONGHUA YANGSHENG BAOJIAN, 2025, 43(12): 39-42.

参考文献

[1] SIEGEL R L,K D MILLER,A JEMAL.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
[2] Hibberd AA, Lyra A, Ouwehand AC, et al.Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention[J].BMJ Open Gastroenterol,2017,4(1):e145.
[3] CHEN M.LI C,LUO Q,et al.LncRNA LINC02257: A Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer[J].J Oncol,2022,2022,1:4330630.
[4] 尤建良,赵景芳,周留勇.中医治疗大肠癌新进展[J].时珍国医国药,2006,17(1):103-104.
[5] 李显晶,宋程,王淳,等.基于生物信息学及分子对接研究益气调腑汤治疗大肠癌的潜在分子机制[J].肿瘤药学,2024,14(5):560-568.
[6] 王皓月,艾静,程悦蕾,等.基于肿瘤相关巨噬细胞代谢重编程探讨大肠癌“脾虚瘀毒”病机[J].中医学报,2025,40(3):481-487.
[7] 林胜友. 780例大肠癌中医证候与生存期的相关性分析[J].中医杂志,2012,53(5):410-412.
[8] 卢文杰. 早期大肠癌及癌前病变中医证候分布规律研究[J].浙江中医杂志,2019,54(7):488-489.
[9] 张涛. 何永恒教授从“毒、虚”辨治结直肠癌经验[J].湖南中医药大学学报,2022,42(6):1023-1028.
[10] 方妍,李柳,程海波.基于湿毒病机探讨祛湿解毒法在恶性肿瘤防治中的应用[J].江苏中医药,2023,55(8):60-63.
[11] 任婉. 温阳止泻方治疗大肠癌术后化疗后脾肾阳虚型患者的临床观察[D].哈尔滨:黑龙江中医药大学,2023.
[12] 王圣子. 四君子汤改善大肠癌术后化疗肠黏膜屏障功能损伤的临床研究[D].上海:上海中医药大学,2021.
[13] 郭礼. 四君子汤联合化疗对大肠癌患者具核梭杆菌的影响及临床疗效观察[D].咸阳:陕西中医药大学,2022.
[14] 薛明杰,孙妍,黄敏.四君子汤治疗大肠癌患者化疗不良反应及对血清PLT、AST、ALT水平变化的影响[J].现代肿瘤医学,2021,29(7):1161-1165.
[15] 欧阳庆武,费雁,魏运姣,等.四君子汤对结肠癌小鼠肠道菌群及免疫功能的调节作用[J].中国老年学杂志,2021,41(21):4819-4823.
[16] 许文科. 槐定碱通过调节ZO-1和CCND1表达抑制结直肠癌的上皮-间质转化、迁移和侵袭的机制研究及基于3D法类器官模型的药物有效性检测[D].南京:南京中医药大学,2024.
[17] 白姣姣. 中药复方及单体治疗结肠癌药效与机制研究进展[J].中国实验方剂学杂志,2023,29(4):246-252.